Pallas Capital Advisors LLC Takes $641,000 Position in Danaher Corporation $DHR

Pallas Capital Advisors LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHRFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 3,367 shares of the conglomerate’s stock, valued at approximately $641,000.

Other institutional investors have also recently bought and sold shares of the company. Main Street Group LTD acquired a new stake in shares of Danaher during the first quarter worth approximately $25,000. N.E.W. Advisory Services LLC acquired a new position in Danaher in the 2nd quarter valued at approximately $25,000. JPL Wealth Management LLC acquired a new position in Danaher in the 3rd quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new stake in Danaher in the 2nd quarter worth approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher in the 4th quarter worth approximately $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the topic of several research analyst reports. JPMorgan Chase & Co. lowered their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Guggenheim cut their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Citigroup started coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective for the company. Wells Fargo & Company lowered their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 22nd. Finally, DZ Bank initiated coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Get Our Latest Stock Analysis on DHR

Danaher Stock Performance

Shares of DHR opened at $211.92 on Thursday. The firm has a market cap of $148.98 billion, a price-to-earnings ratio of 37.64, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78. The company’s fifty day moving average is $194.30 and its 200-day moving average is $192.44. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 EPS. Equities analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.